Table 1 Baseline data of patients with ischemic stroke (I63.*) and data on mRS at discharge, with a time window</=24 h in the years 2018 and 2019 with respect to endovascular stroke treatment (N = 38,301)
From: Outcome of endovascular stroke therapy in a large mandatory stroke-registry
Endovascular stroke treatment done | No endovascular stroke treatment | |
|---|---|---|
Number of patients | 3745 | 34,556 |
Female [n (%)] | 1958 (52.3) | 15,739 (45.6) |
Age [Median (IQR)] | 78 (16) | 77 (16) |
mRS admission [Median (IQR)] | 5 (1) | 3 (2) |
NIHSS admission [Median (IQR)] | 14 (10) | 3 (5) |
Non invasive vessel diagnosis [n (%)] | 3745 (100) | 21,248 (61.49) |
Intracranial vessel occlusion [n (%)] | 3745 (100) | 3436 (9.94) |
Intravenous thrombolysis [n (%)] | 2059 (55.0) | 7665 (22.2) |
Time window</=5 h [n (%)] | 2919 (77.9) | 20,055 (58.0) |
Diabetes mellitus [n (%)] | 776 (20.7)* | 8698 (25.2) |
Hypertension [n (%)] | 2940 (78.5)* | 28,362 (82.1) |
Atrial fibrillation [n (%)] | 1804 (48.2) * | 9819 (28.4) |
Previously known | 1222 (32.6) | 7180 (20.8) |
Newly diagnosed | 582 (15.5) | 2639 (7.6) |